Refine by
18 results found
-
NAMI Seeks Participants for Survey on Treatment and Clinical Research of Schizophrenia
NAMI is seeking adults with a diagnosis of schizophrenia and adult family members/care partners of people with a diagnosis of schizophrenia to participate in an anonymous online survey. -
NAMI Hosting Free, Virtual Inspiring Hope Through Research Event
This year’s award honoree, Dr. David C. Henderson, is the Psychiatrist-in-Chief at Boston Medical Center and Professor and Chair of Psychiatry at Boston University School of Medicine. -
NAMI Joins Public–Private Partnership to Advance Early Interventions for Schizophrenia
Today, NAMI announced it has joined the Accelerating Medicines Partnership (AMP) Schizophrenia (SCZ), which brings together NIH, the U.S. Food and Drug Administration and multiple non-profit and private organizations to work toward meeting the urgent need for early therapeutic interventions for people at risk of developing schizophrenia. -
Q&A with NIMH Director Dr. Josh Gordon
NAMI asks NIMH director, Dr. Josh Gordon, about the future of mental illness research. -
Substance Use Carries Mental Health Risks—Yes, Even Marijuana
"We know serious mental illness and substance use disorders often co-occur. And I believe there is room for researching the medical potential of marijuana’s components. But pretending that marijuana is a harmless substance is not the way to help our loved ones." -
Keys to Managing Schizophrenia
"Schizophrenia is not a hopeless situation—people living with schizophrenia can experience recovery and live fulfilling lives. I’m an example of that." -
Outreach and Engagement for Early Psychosis
A first episode of psychosis can be scary and isolating. Treatment can have little appeal and feel highly stigmatizing. Recovery-Oriented Cognitive Therapy is an evidence-based approach that skirts these (and many other) common challenges of working with young adults who have psychosis. -
Taking Another Look a Too-Often-Forgotten Treatment for Schizophrenia
We don’t endorse specific treatments at NAMI, but in my role as medical director, I always like to remind people about clozapine. The consensus in the medical community is that, generally speaking, it is an underutilized treatment.
-
Understanding Psychotic Breaks
Psychosis is a complex mental health symptom that over 100,000 young people experience each year. Understand what causes psychosis, how to identify symptoms and how to support someone who may be experiencing it. -
Leader of Landmark Gene Research on Schizophrenia to Speak at NAMI Convention
Dr. Steven McCarroll, who led the research team responsible for a study that examines the gene that may be a risk factor for schizophrenia, will speak at this year’s NAMI National Convention, July 6–9 in Denver.